Trial Details
NOT_YET_RECRUITINGBasic Information
| Clinical ID | c348 |
|---|---|
| Identifier | NCT06727422 |
| Trial Title | Efficacy of Rifaximin With NAC in IBS-D |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | IBS (Irritable Bowel Syndrome)|IBS-D (Diarrhea-predominant) |
| Interventions | DRUG: rifaximin 66mg + N-acetylcysteine 560mg three times daily|DRUG: RNIB21 containing rifaximin 132mg + N-acetylcysteine 560mg three times daily|DRUG: Placebo |
Participant Information
| Sponsor | Mark Pimentel, MD |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-12-15 |
|---|---|
| Primary Completion Date | 2026-04-01 |
| Completion Date | 2027-01-01 |